查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1619670

2024 年植入式神經刺激設備全球市場報告

Implantable Neurostimulation Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

植入式神經刺激設備市場預計在未來幾年將快速成長。 2028年將以10.9%的年複合成長率（CAGR）成長至131.3億美元。預測期內的成長是由於神經系統疾病盛行率上升、文明病增加、意識提高、脊髓損傷增加以及醫療保健支出增加。預測期內預計的主要趨勢包括感測技術的進步、神經刺激技術的進步、技術先進產品的開發、閉合迴路系統的結合以及無線技術的整合。

神經系統疾病盛行率的增加預計將推動植入式神經刺激設備市場的未來成長。神經病變是一種影響神經系統結構和功能的疾病，導致多種症狀，如癱瘓、癲癇發作和認知障礙。高血壓、發育異常以及創傷或傷害等因素導致這些疾病的檢出率增加。當其他治療無效或不充分時，植入式神經刺激設備用於調節神經活動並緩解症狀。例如，美國非營利組織阿茲海默症症協會預測，到2024年，約有690萬美國年齡在65歲及以上，其中73%的人在75歲及以上患有阿茲海默症。預計到 2050 年，這一數字將增至 1,270 萬。因此，神經系統疾病盛行率的上升預計將推動植入式神經刺激設備市場的成長。

植入式神經刺激設備市場的主要參與企業正在開發脊髓刺激 (SCS) 系統等先進技術，以解決慢性疼痛問題。 SCS 系統是醫療設備，使用電脈衝調節脊髓神經活動，在其他治療失敗時緩解疼痛並改善患者的生活品質。例如，2022 年 12 月，美國醫療設備製造商雅培 (Abbott) 的 Eterna 脊髓刺激 (SCS) 系統獲得 FDA核准。 Eterna SCS 是市面上最小的可充電植入式脊髓刺激設備，旨在實現最大的舒適度。它採用 Abbott 的 BurstDR 刺激技術，模仿自然的大腦放電模式，以增強疼痛緩解效果，與傳統的刺痛刺激相比，87% 的患者更喜歡這種刺激。採用 Xtend 能量技術，Eterna 每年只需充電五次，並與 TotalScan 技術的全身 MRI 掃描相容。它還可以適應未來的進步，而無需更換。與 Abbott 行動應用程式整合可讓您在 iPhone 裝置上即時追蹤電池電量和充電狀態。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球植入式神經刺激設備市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球植入式神經刺激設備市場表現：規模與成長，2018-2023
  • 全球植入式神經刺激設備市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球植入式神經刺激設備市場：按類型、性能和預測，2018-2023、2023-2028、2033
  • 脊髓刺激 (SCS)
  • 胃電刺激（GES）
  • 深部腦部刺激（DBS）
  • 薦椎神經刺激（SNS）
  • 迷走神經刺激 (VNS)
  • 其他
  • 全球植入式神經刺激設備市場：按應用、性能和預測分類，2018-2023、2023-2028、2033
  • 疼痛管理
  • 帕金森氏症
  • 尿失禁和大便失禁
  • 癲癇
  • 胃輕癱
  • 其他
  • 全球植入式神經刺激設備市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診所
  • 門診手術中心

第 7 章 區域/國家分析

  • 全球植入式神經刺激設備市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球植入式神經刺激設備市場：按國家、表現和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 植入式神經刺激設備市場：競爭格局
  • 植入式神經刺激設備市場：公司簡介
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • Dignity Health
    • St. Jude Medical LLC

第31章 其他重大及創新企業

  • LivaNova PLC
  • Nevro Corp.
  • Axonics Inc.
  • NeuroPace Inc.
  • Bioness Inc.
  • Saluda Medical Pty Ltd.
  • SceneRay Co. Ltd.
  • NeuroMetrix Inc.
  • CURE Epilepsy
  • Synapse Biomedical Inc.
  • NeuroSigma Inc.
  • Nuvectra Corporation
  • MicroTransponder Inc.
  • Pain Management NYC
  • Curonix LLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20675

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $7.83 billion in 2023 to $8.68 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth during the historical period can be attributed to the rising demand for non-pharmacological treatments, the increasing preference for minimally invasive procedures, the expanding geriatric population, a broader range of psychiatric disorders, and the growing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $13.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth during the forecast period can be attributed to the rising prevalence of neurological disorders, an increase in lifestyle-related diseases, growing awareness, a rise in spinal cord injuries, and increasing healthcare expenditure. Key trends expected in the forecast period include advancements in sensing technology, progress in neurostimulation technologies, development of technologically advanced products, the incorporation of closed-loop systems, and the integration of wireless technology.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the implantable neurostimulation device market in the future. Neurological disorders are conditions that impact the structure or function of the nervous system, leading to a range of symptoms such as paralysis, seizures, and cognitive impairments. Factors such as high blood pressure, developmental abnormalities, and trauma or injury contribute to higher detection rates of these disorders. Implantable neurostimulation devices are utilized to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient. For example, in 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with 73% being 75 years or older. This figure is projected to increase to 12.7 million by 2050. Consequently, the rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market.

Key players in the implantable neurostimulation devices market are developing advanced technologies, such as spinal cord stimulation (SCS) systems, to address chronic pain conditions. An SCS system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord, providing pain relief and improving patient quality of life when other treatments fail. For instance, in December 2022, Abbott, a U.S.-based medical device company, received FDA approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the smallest rechargeable implantable spinal cord stimulator on the market, designed for maximum comfort. It features Abbott's BurstDR stimulation technology, which replicates natural brain firing patterns for enhanced pain relief and is preferred by 87% of patients over traditional tingling stimulation. Eterna requires as few as five recharges annually due to Xtend energy technology and supports full-body MRI scans with TotalScan technology. It is also adaptable to future advancements without replacement. Abbott's mobile app integration allows real-time tracking of battery life and charging status on iPhone devices.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition gives Amber access to valuable hardware, expertise, and manufacturing experience, accelerating the development and commercialization of Amber-UI. Bioinduction is a UK-based manufacturer specializing in implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

North America was the largest region in the implantable neurostimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Dignity Health; St. Jude Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Neurostimulation Devices Market Characteristics

3. Implantable Neurostimulation Devices Market Trends And Strategies

4. Implantable Neurostimulation Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Implantable Neurostimulation Devices Market Size and Growth

  • 5.1. Global Implantable Neurostimulation Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Implantable Neurostimulation Devices Market Segmentation

  • 6.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Types
  • 6.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Parkinson's Disease
  • Urinary And Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Other Applications
  • 6.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

7. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Implantable Neurostimulation Devices Market

  • 8.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Implantable Neurostimulation Devices Market

  • 9.1. China Implantable Neurostimulation Devices Market Overview
  • 9.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Implantable Neurostimulation Devices Market

  • 10.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Implantable Neurostimulation Devices Market

  • 11.1. Japan Implantable Neurostimulation Devices Market Overview
  • 11.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Implantable Neurostimulation Devices Market

  • 12.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Implantable Neurostimulation Devices Market

  • 13.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Implantable Neurostimulation Devices Market

  • 14.1. South Korea Implantable Neurostimulation Devices Market Overview
  • 14.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Implantable Neurostimulation Devices Market

  • 15.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • 15.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Implantable Neurostimulation Devices Market

  • 16.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Implantable Neurostimulation Devices Market

  • 17.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Implantable Neurostimulation Devices Market

  • 18.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Implantable Neurostimulation Devices Market

  • 19.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Implantable Neurostimulation Devices Market

  • 20.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Implantable Neurostimulation Devices Market

  • 21.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Implantable Neurostimulation Devices Market

  • 22.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Implantable Neurostimulation Devices Market

  • 23.1. North America Implantable Neurostimulation Devices Market Overview
  • 23.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Implantable Neurostimulation Devices Market

  • 24.1. USA Implantable Neurostimulation Devices Market Overview
  • 24.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Implantable Neurostimulation Devices Market

  • 25.1. Canada Implantable Neurostimulation Devices Market Overview
  • 25.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Implantable Neurostimulation Devices Market

  • 26.1. South America Implantable Neurostimulation Devices Market Overview
  • 26.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Implantable Neurostimulation Devices Market

  • 27.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Implantable Neurostimulation Devices Market

  • 28.1. Middle East Implantable Neurostimulation Devices Market Overview
  • 28.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Implantable Neurostimulation Devices Market

  • 29.1. Africa Implantable Neurostimulation Devices Market Overview
  • 29.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Neurostimulation Devices Market Competitive Landscape
  • 30.2. Implantable Neurostimulation Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Dignity Health
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. St. Jude Medical LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Nevro Corp.
  • 31.3. Axonics Inc.
  • 31.4. NeuroPace Inc.
  • 31.5. Bioness Inc.
  • 31.6. Saluda Medical Pty Ltd.
  • 31.7. SceneRay Co. Ltd.
  • 31.8. NeuroMetrix Inc.
  • 31.9. CURE Epilepsy
  • 31.10. Synapse Biomedical Inc.
  • 31.11. NeuroSigma Inc.
  • 31.12. Nuvectra Corporation
  • 31.13. MicroTransponder Inc.
  • 31.14. Pain Management NYC
  • 31.15. Curonix LLC

32. Global Implantable Neurostimulation Devices Market Competitive Benchmarking

33. Global Implantable Neurostimulation Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

35. Implantable Neurostimulation Devices Market Future Outlook and Potential Analysis

  • 35.1 Implantable Neurostimulation Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Implantable Neurostimulation Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Implantable Neurostimulation Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer